Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery: A Double Blind Randomized Control Trial

NCT03535116 is registered in ClinicalTrials.gov with Dr. Chandran Medical Prof Corp as lead sponsor.

NCT NCT03535116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03535116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery: A Double Blind Randomized Control Trial
Lead sponsor
Dr. Chandran Medical Prof Corp
Phase
Phase 4
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 31, 2024
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematoma postoperative